Clinical Cardiology Alert – October 1, 2010
October 1, 2010
View Issues
-
Aspirin and Clopidogrel Dose in ACS
For patients presenting with acute coronary syndromes (ACS), the optimal doses of aspirin and clopidogrel remain unknown. -
No Role for Elective IABP in High-risk PCI
Patients with extensive coronary artery disease (CAD) and left ventricular (LV) dysfunction are at high risk during revascularization. -
Role of HDL Cholesterol in Residual Risk for CAD
Despite impressive reductions in cardiovascular risk in primary and secondary prevention trails with statin therapy, risk does not reach zero. -
Predictive Value of NSVT in Non-ST Elevation Acute Coronary Syndromes
Merlin-timi 36 tested the hypothesis that ranolazine, a recently approved anti-anginal agent, would benefit patients with non-ST-elevation acute coronary syndrome (NSTEACS). -
Sinus of Valsalva Origin of Atrial Tachycardia
In this report, Liu and colleagues describe the electrophysiologic characteristics of atrial tachycardias (AT) that arise from the noncoronary aortic sinus (NCAS). -
Value of Preoperative Consultations
Patients undergoing major surgery tend to be older individuals with more comorbidities than the general non-surgical population. -
SVT and Ischemia
Supraventricular tachycardia (SVT) is known to be associated with troponin leaks and ST-wave depression on ECG, both potential markers of ischemia. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.